These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1249 related items for PubMed ID: 30197475

  • 1. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
    Mumolo MG, Bertani L, Ceccarelli L, Laino G, Di Fluri G, Albano E, Tapete G, Costa F.
    World J Gastroenterol; 2018 Sep 07; 24(33):3681-3694. PubMed ID: 30197475
    [Abstract] [Full Text] [Related]

  • 2. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G.
    World J Gastroenterol; 2017 Nov 07; 23(41):7387-7396. PubMed ID: 29151692
    [Abstract] [Full Text] [Related]

  • 3. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec 07; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T, Portincasa P, Koutroubakis IE.
    J Gastrointestin Liver Dis; 2018 Sep 14; 27(3):299-306. PubMed ID: 30240474
    [Abstract] [Full Text] [Related]

  • 8. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Dig Dis Sci; 2017 Nov 14; 62(11):3123-3130. PubMed ID: 28948412
    [Abstract] [Full Text] [Related]

  • 9. Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
    Ferreiro-Iglesias R, Barreiro-de Acosta M, Otero Santiago M, Lorenzo Gonzalez A, Alonso de la Peña C, Benitez Estevez AJ, Dominguez-Muñoz JE.
    J Clin Gastroenterol; 2016 Feb 14; 50(2):147-51. PubMed ID: 25811118
    [Abstract] [Full Text] [Related]

  • 10. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
    Rosenfeld G, Greenup AJ, Round A, Takach O, Halparin L, Saadeddin A, Ho JK, Lee T, Enns R, Bressler B.
    World J Gastroenterol; 2016 Sep 28; 22(36):8211-8. PubMed ID: 27688663
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
    Tursi A, Elisei W, Picchio M, Giorgetti G, Brandimarte G.
    Dig Dis Sci; 2015 May 28; 60(5):1406-13. PubMed ID: 25445163
    [Abstract] [Full Text] [Related]

  • 12. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov 28; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G, Hayee B, Maestranzi S, Donaldson N, Forgacs I, Sherwood R.
    Inflamm Bowel Dis; 2007 Nov 28; 13(11):1374-8. PubMed ID: 17577247
    [Abstract] [Full Text] [Related]

  • 15. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.
    J Gastrointestin Liver Dis; 2014 Sep 28; 23(3):273-8. PubMed ID: 25267955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.
    Lin WC, Wong JM, Tung CC, Lin CP, Chou JW, Wang HY, Shieh MJ, Chang CH, Liu HH, Wei SC, Taiwan Society of Inflammatory Bowel Disease Multicenter Study.
    World J Gastroenterol; 2015 Dec 28; 21(48):13566-73. PubMed ID: 26730169
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.